[The case studies on oral administration of tegafur encapsulated with slow releasing granule (SF-SP) for three rectal patients].
Three rectal cancer patients with partial response (PR) were obtained by oral administration of 800-1200 mg/day of SF-SP. One of them showed I-A grade and other I-B in Karnofsky evaluation.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000284:Administration, Oral; D000368:Aged; D002214:Capsules; D003692:Delayed-Action Preparations; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage*
D002214:Capsules; D003692:Delayed-Action Preparations; D005641:Tegafur; D005472:Fluorouracil